Cargando…
A Randomised Trial of Subcutaneous Intermittent Interleukin-2 without Antiretroviral Therapy in HIV-Infected Patients: The UK–Vanguard Study
OBJECTIVE: The objective of the trial was to evaluate in a pilot setting the safety and efficacy of interleukin-2 (IL-2) therapy when used without concomitant antiretroviral therapy as a treatment for HIV infection. DESIGN AND SETTING: This was a multicentre randomised three-arm trial conducted betw...
Autores principales: | Youle, Mike, Emery, Sean, Fisher, Martin, Nelson, Mark, Fosdick, Lisa, Janossy, George, Loveday, Clive, Sullivan, Ann, Herzmann, Christian, Wand, Handan, Davey, Richard T, Johnson, Margaret A, Tavel, Jorge A, Lane, H. Clifford |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1488892/ https://www.ncbi.nlm.nih.gov/pubmed/16871325 http://dx.doi.org/10.1371/journal.pctr.0010003 |
Ejemplares similares
-
Correction: A Randomised Trial of Subcutaneous Intermittent Interleukin-2 without Antiretroviral Therapy in HIV-Infected Patients: The UK-Vanguard Study
Publicado: (2007) -
The Vanguard
Publicado: (1888) -
Wailin' at the Vanguard
por: Taylor, Art
Publicado: (1993) -
Vanguard management: redesigning the corporate future
por: O'Toole, James
Publicado: (1985) -
Vanguard revolutionaries in Latin America : Peru, Colombia, Mexico
por: Rochlin, James Francis, 1956-
Publicado: (2003)